We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NKGN NKGen Biotech Inc

-0.0749 (-2.17%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 48,980
Bid Price 3.30
Ask Price 3.53
News -
Day High 3.52


52 Week Range


Day Low 3.31
Company Name Stock Ticker Symbol Market Type
NKGen Biotech Inc NKGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0749 -2.17% 3.375 18:00:04
Open Price Low Price High Price Close Price Prev Close
3.43 3.31 3.52 3.375 3.4499
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
493 48,980 $ 3.44 $ 168,333 - 2.73 - 6.70
Last Trade Time Type Quantity Stock Price Currency
19:46:22 10 $ 3.38 USD

NKGen Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
73.77M 21.89M - 0 4.55M 0.21 16.22
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NKGen Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NKGN Message Board. Create One! See More Posts on NKGN Message Board See More Message Board Posts

Historical NKGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.943.522.833.2952,1220.43514.8%
1 Month3.063.522.733.1044,6650.31510.29%
3 Months5.986.702.733.48207,118-2.61-43.56%
6 Months5.986.702.733.48207,118-2.61-43.56%
1 Year5.986.702.733.48207,118-2.61-43.56%
3 Years5.986.702.733.48207,118-2.61-43.56%
5 Years5.986.702.733.48207,118-2.61-43.56%

NKGen Biotech Description

NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in neurodegeneration and immune-oncology and are passionate and excited about the work we are doing to strengthen the immune system.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |